Nasdaq, Inc.
NASDAQ:NDAQFinancial - Data & Stock Exchanges
-$0.92 today
- Market cap
- $58.34B
- Beta
- 0.97
- P/E (TTM)
- 24.4
- EPS (TTM)
- $3.38
- Dividend yield
- 1.36%
Volume 2.61M
Average 3.15M
NDAQ Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Nasdaq, Inc.NASDAQ: NDAQ
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How NDAQ compares with its peers on the latest reported figures
- NDAQ's LTM Sep 2026 research & development of $0 is the highest of the 3 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for NDAQ, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding NDAQ) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for NDAQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 5.89B | 6.23B | 6.06B | 7.4B | 8.22B |
| Cost of Revenue | 3.65B | 3.89B | 3.52B | 4.41B | 4.28B |
| Gross Profit | 2.23B | 2.34B | 2.55B | 2.99B | 3.94B |
| Gross Margin | 37.9% | 37.6% | 42.0% | 40.4% | 47.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 395M | 420M | 417M | 427M | 140M |
| Operating Expenses | 791M | 775M | 968M | 1.19B | 1.61B |
| Depreciation & Amortization | 278M | 258M | 323M | 613M | 632M |
| EBITDA | 1.93B | 1.85B | 2B | 2.46B | 3.13B |
| EBITDA Margin | 32.7% | 29.8% | 32.9% | 33.2% | 38.0% |
| Operating Income | 1.44B | 1.56B | 1.58B | 1.8B | 2.33B |
| Operating Margin | 24.5% | 25.1% | 26.0% | 24.3% | 28.4% |
| Interest Income | 1M | 7M | 115M | 28M | 38M |
| Interest Expense | 0 | 0 | 0 | 0 | 88M |
| Other Income / Expenses | 93M | (89M) | (177M) | (349M) | (186M) |
| Income Before Tax | 1.53B | 1.48B | 1.4B | 1.45B | 2.15B |
| Pre-Tax Margin | 26.1% | 23.7% | 23.1% | 19.6% | 26.1% |
| Income Tax Expense | 347M | 352M | 344M | 334M | 356M |
| Net Income | 1.19B | 1.13B | 1.06B | 1.12B | 1.79B |
| Net Margin | 20.2% | 18.1% | 17.5% | 15.1% | 21.8% |
| EPS (Basic) | 2.38 | 2.28 | 2.10 | 1.94 | 3.13 |
| EPS (Diluted) | 2.35 | 2.26 | 2.08 | 1.93 | 3.09 |
| Weighted Avg Shares | 497.7M | 492.42M | 508.39M | 575.12M | 570.7M |
| Weighted Avg Shares (Diluted) | 505.09M | 497.86M | 508.39M | 579.2M | 576.5M |
Nasdaq, Inc.
NASDAQ:NDAQ
Intrinsic Alpha fair value
Locked
Current Price
$105.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.